Overview
Takehiko Doi practices in Obu, Japan. Doi is rated as an Advanced expert by MediFind in the treatment of Hemosiderosis. Their top areas of expertise are Idiopathic Pulmonary Hemosiderosis, Hemosiderosis, Reticulohistiocytoma, Osteotomy, and Splenectomy.
Their clinical research consists of co-authoring 259 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hemosiderosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Idiopathic Pulmonary Hemosiderosis
- Advanced
- DementiaDoi isAdvanced. Learn about Dementia.
- Developmental Dysphasia Familial
- Hemophagocytic Lymphohistiocytosis
- HemosiderosisDoi isAdvanced. Learn about Hemosiderosis.
- HistiocytosisDoi isAdvanced. Learn about Histiocytosis.
- Langerhans Cell Histiocytosis
- Experienced
- Acute Interstitial Pneumonia
- Acute PainDoi isExperienced. Learn about Acute Pain.
- ADULT SyndromeDoi isExperienced. Learn about ADULT Syndrome.
- Alzheimer's DiseaseDoi isExperienced. Learn about Alzheimer's Disease.
- Blood ClotsDoi isExperienced. Learn about Blood Clots.
- CACH SyndromeDoi isExperienced. Learn about CACH Syndrome.